Protection of pancreatic β-cells by group VIA phospholipase A 2-mediated repair of mitochondrial membrane peroxidation

Endocrinology

Volumn 151, Issue 7, 2010, Pages 3038-3048

  Zhao, Zhengshan ^a   Zhang, Xu ^a   Zhao, Chunying ^a   Choi, Jinwoo ^a   Shi, Jieyi ^a   Song, Keying ^a   Turk, John ^b   Ma, Zhongmin Alex ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; BROMOENOL LACTONE; CALCIUM INDEPENDENT PHOSPHOLIPASE A2; CARDIOLIPIN; CASPASE 3; CYTOCHROME C; FATTY ACID; GLUCOSE; HYDROXYLAMINE; INSULIN; N TERT BUTYLHYDROXYLAMINE; STAUROSPORINE; UNCLASSIFIED DRUG; PALMITIC ACID; PHOSPHOLIPASE A2 GROUP VI; PHOSPHOLIPID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVATION; GLUCOSE TOLERANCE; INSULIN RELEASE; INSULINOMA; LIPID PEROXIDATION; MALE; MITOCHONDRIAL MEMBRANE; MOUSE; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; ANIMAL; CELL CULTURE; DRUG EFFECT; GENETICS; GLUCOSE TOLERANCE TEST; IMMUNOHISTOCHEMISTRY; METABOLISM; MITOCHONDRIAL MEMBRANE POTENTIAL; MOUSE MUTANT; PANCREAS ISLET; RANDOMIZATION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CARDIOLIPINS; CASPASE 3; CELLS, CULTURED; CYTOCHROMES C; GLUCOSE; GLUCOSE TOLERANCE TEST; GROUP VI PHOSPHOLIPASES A2; IMMUNOHISTOCHEMISTRY; INSULIN; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; LIPID PEROXIDATION; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICE; MICE, KNOCKOUT; MITOCHONDRIAL MEMBRANES; PALMITIC ACID; PHOSPHOLIPIDS; RANDOM ALLOCATION; STAUROSPORINE;

EID: 77954576363     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-0016     Document Type: Article

References (48)

1. Mathis D, Vence L, Benoist C 2001 β-Cell death during progression to diabetes. Nature 414:792-798
2. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC 2003 β-Cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102-110
3. Prentki M, Nolan CJ 2006 Islet β cell failure in type 2 diabetes. J Clin Invest 116:1802-1812
4. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ 1993 Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241-251
5. Kagan VE, Tyurin VA, Jiang J, Tyurina YY, Ritov VB, Amoscato AA, Osipov AN, Belikova NA, Kapralov AA, Kini V, Vlasova II, Zhao Q, Zou M, Di P, Svistunenko DA, Kurnikov IV, Borisenko GG 2005 Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nat Chem Biol 1:223-232
6. Ott M, Robertson JD, Gogvadze V, Zhivotovsky B, Orrenius S 2002 Cytochrome c release from mitochondria proceeds by a two-step process. Proc Natl Acad Sci USA 99:1259-1263
7. Ott M, Zhivotovsky B, Orrenius S 2007 Role of cardiolipin in cytochrome c release from mitochondria. Cell Death Differ 14:1243-1247
8. Schug ZT, Gottlieb E 2009 Cardiolipin acts as a mitochondrial signalling platform to launch apoptosis. Biochim Biophys Acta 1788:2022-2031
9. Schlame M, Rua D, Greenberg ML 2000 The biosynthesis and functional role of cardiolipin. Prog Lipid Res 39:257-288
10. Turk J, Wolf BA, Lefkowith JB, Stump WT, McDaniel ML 1986 Glucose-induced phospholipid hydrolysis in isolated pancreatic islets: quantitative effects on the phospholipid content of arachidonate and other fatty acids. Biochim Biophys Acta 879:399-409
11. Bione S, D'Adamo P, Maestrini E, Gedeon AK, Bolhuis PA, Toniolo D 1996 A novel X-linked gene, G4.5. is responsible for Barth syndrome. Nat Genet 12:385-389
12. Vreken P, Valianpour F, Nijtmans LG, Grivell LA, Plecko B, Wanders RJA, Barth PG 2000 Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome. Biochem Bioph Res Commun 279:378-382
13. 2. Prog Nucleic Acids Res Mol Biol 67:1-33
14. 2 prevents arachidonic acid incorporation and phospholipid remodeling in P388D1 macrophages. Proc Natl Acad Sci USA 92:8527-8531
15. 2 in the pathogenesis of Barth syndrome. Proc Natl Acad Sci USA 106:2337-2341
16. 2 localizes in and protects mitochondria during apoptotic induction by staurosporine. J Biol Chem 281:22275-22288
17. Cai J, Jones DP 1998 Superoxide in apoptosis. Mitochondrial generation triggered by cytochrome c loss. J Biol Chem 273:11401-11404
18. 2 and effects of metabolic stress on glucose homeostasis. J Biol Chem 281:20958-20973
19. 2 produce spermatozoa with impaired motility and have greatly reduced fertility. J Biol Chem 279:38194-38200
20. Zhao Z, Zhao C, Zhang XH, Zheng F, Cai W, Vlassara H, Ma ZA 2009 Advanced glycation end products inhibit glucose-stimulated insulin secretion through nitric oxide-dependent inhibition of cytochrome c oxidase and adenosine triphosphate synthesis. Endocrinology 150:2569-2576
21. Zhao Z, Lee YJ, Kim SK, Kim HJ, Shim WS, Ahn CW, Lee HC, Cha BS, Ma ZA 2009 Rosiglitazone and fenofibrate improve insulin sensitivity of pre-diabetic OLETF rats by reducing malonyl-CoA levels in the liver and skeletal muscle. Life Sci 84:688-695
22. Ma Z, Bohrer A, Wohltmann M, Ramanadham S, Hsu FF, Turk J 2001 Studies of phospholipid metabolism, proliferation, and secretion of stably transfected insulinoma cells that overexpress group VIA phospholipase A2. Lipids 36:689-700
23. 2 induces a p53-dependent cell-cycle arrest in G1 phase. J Cell Sci 119:1005-1015
24. Zhang XH, Zhao C, Ma ZA 2007 The increase of cell-membranous phosphatidylcholines containing polyunsaturated fatty acid residues induces phosphorylation of p53 through activation of ATR. J Cell Sci 120:4134-4143
25. Yagi K 1998 Simple procedure for specific assay of lipid hydroperoxides in serum or plasma. Methods Mol Biol 108:107-110
26. 2 results in insufficient insulin secretion and impaired glucose tolerance. Mol Endocrinol 19:504-515
27. Wolever TM, Jenkins DJ, Jenkins AL, Josse RG 1991 The glycemic index: methodology and clinical implications. Am J Clin Nutr 54:846-854
28. Krauss S, Zhang CY, Scorrano L, Dalgaard LT, St-Pierre J, Grey ST, Lowell BB 2003 Superoxide-mediated activation of uncoupling protein 2 causes pancreatic β cell dysfunction. J Clin Invest 112:1831-1842
29. Maechler P, Wollheim CB 2001 Mitochondrial function in normal and diabetic β-cells. Nature 414:807-812
30. Lowell BB, Shulman GI 2005 Mitochondrial dysfunction and type 2 diabetes. Science 307:384-387
31. 2 enzymes: classification and characterization. Biochim Biophys Acta 1488:1-19
32. Sevanian A 1988 Lipid damage and repair. In: Davies K, ed. Oxidative damage and repair. New York: Pergamon Press; 543-549
33. Sevanian A, Hochstein P 1985 Mechanisms and consequences of lipid peroxidation in biological systems. Annu Rev Nutr 5:365-390
34. 2s and lipid peroxidation. Biochim Biophys Acta 1488:167-181
35. 2, is mutated in neurodegenerative disorders with high brain iron. Nat Genet 38:752-754
36. Klingenberg M 2009 Cardiolipin and mitochondrial carriers. Biochim Biophys Acta 1788:2048-2058
37. 2, which undergoes proteolytic inactivation. J Biol Chem 273:13870-13877
38. Lauber K, Bohn E, Kröber SM, Xiao YJ, Blumenthal SG, Lindemann RK, Marini P, Wiedig C, Zobywalski A, Baksh S, Xu Y, Autenrieth IB, Schulze-Osthoff K, Belka C, Stuhler G, Wesselborg S 2003 Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal. Cell 113:717-730
39. 2β, precipitating ventricular tachyar-rhythmias in transgenic mice: rescue of the lethal electrophysiologic phenotype by mechanism-based inhibition. J Biol Chem 278:22231-22236
40. 2 in arachidonic acid release, phospholipid fatty acid incorporation, and apoptosis in U937 cells responding to hydrogen peroxide. J Biol Chem 279:40385-40391
41. 2 β)-mediated ceramide generation plays a key role in the cross-talk between the endoplasmic reticulum (ER) and mitochondria during ER stress-induced insulin-secreting cell apoptosis. J Biol Chem 283:34819-34832
42. 2 participates in ER stress-induced INS-1 insulinoma cell apoptosis by promoting ceramide generation via hydrolysis of sphingomyelins by neutral sphingomyelinase. Biochemistry 46:10170-10185
43. Lauber K, Blumenthal SG, Waibel M, Wesselborg S 2004 Clearance of apoptotic cells: getting rid of the corpses. Mol Cell 14:277-287
44. Michlewska S, McColl A, Rossi AG, Megson IL, Dransfield I 2007 Clearance of dying cells and autoimmunity. Autoimmunity 40:267-273
45. Fernandes G, Handwerger BS, Yunis EJ, Brown DM 1978 Immune response in the mutant diabetic C57BL/Ks-dt+ mouse. Discrepancies between in vitro and in vivo immunological assays. J Clin Invest 61:243-250
46. Mandel MA, Mahmoud AA 1978 Impairment of cell-mediated immunity in mutation diabetic mice (db/db). J Immunol 120:1375-1377
47. Debray-Sachs M, Dardenne M, Sai P, Savino W, Quiniou MC, Boillot D, Gepts W, Assan R 1983 Anti-islet immunity and thymic dysfunction in the mutant diabetic C57BL/KsJ db/db mouse. Diabetes 32:1048-1054
48. Debray-Sachs M, Saï P, Boitard C, Assan R, Hamburger J 1983 Anti-pancreatic immunity in genetically diabetic mice. Clin Exp Immunol 51:1-7